November 21st, 2014

Encouraging Results For Two New Drugs For Hyperkalemia

Two new agents under development may help curb and prevent hyperkalemia, the common and serious side effect of drugs that inhibit the renin-angiotensin-aldosterone system (RAAS), which are the cornerstones of the treatment of chronic kidney disease and heart failure.

Click here to read the full post on Forbes.


Comments are closed.